BRAWN logo

Brawn Biotech Ltd

BRAWN·BSE·
₹25.40▲ +0.00 (+0.00%)
Market Cap7.62 Cr
PE Ratio7.79
Volume24
Day High - Low25.40 - 25.40
52W High-Low25.70 - 17.71

Brawn Biotech Ltd (BRAWN): company summary

Annual revenue rose 26.1% to ₹17 crore, while annual net profit swung from a net loss of ₹2 crore to a profit of ₹1 crore.

Brawn Biotech Ltd (BRAWN) is a micro-cap Healthcare company valued at ₹8 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Brawn Biotech Ltd last traded at ₹25.4, unchanged on the day.
Financial performance
Annual revenue rose 26.1% to ₹17 crore, while annual net profit swung from a net loss of ₹2 crore to a profit of ₹1 crore. The latest quarter saw revenue rise 4.8% year-on-year to ₹6 crore, but net profit fell 37.5% to ₹0 crore.
Valuation multiples
The stock trades at 7.8 times earnings, a discount to the Healthcare median of 32.0, 1.61 times book value.
Things to watch
Net profit margin improved 18.9 percentage points to 5.5%, but the latest quarter net profit fell 37.5% to ₹0 crore. The stock is 1.2% below its 52-week high of ₹25.70.
Where it stands
Brawn Biotech Ltd reported a net profit of ₹1 crore for the fiscal year ending March 2026, up from a net loss of ₹2 crore the previous year. The latest quarter net profit fell 37.5% to ₹0 crore.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.9/10
Weak
Fair Value
Sign in to see
ROE
21.67%
Strong
P/E
7.79x
Cheap
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W₹17.71
₹25.70
DocStoX take

Supported by valuation (9.0) and momentum (7.5), but held back by growth (1.5). Valuation looks strong at 9.0, but that is offset by growth at 1.5 and quality at 2.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.9
/10
Weak
Quality
Weak
ROE 21.7%
Valuation
Cheap
P/E 7.8×
Growth
Flat
Revenue -13.5% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Strong
96% of 52-week range

At a glance

Market Cap
₹8 Cr
52W High / Low
₹26 / ₹18
Dividend Yield
0.00%
Promoter Holding
52.94%
EPS (TTM)
₹3.26
Book Value
₹14.46

Key highlights

  • Low leverage — D/E 0.00
  • Undemanding at 8× earnings
  • Strong returns on equity (22%)
  • Profit shrinking 0% a year
  • Revenue shrinking 13% a year
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Brawn Biotech Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.